Island Pharmaceuticals Limited (ASX:ILA)
Australia · Delayed Price · Currency is AUD 0.4700
+0.0050 (1.08%)
Aug 11, 2026, 3:49 PM AEST
Island Pharmaceuticals Market Cap
Island Pharmaceuticals has a market cap or net worth of 139.08 million as of August 11, 2026. Its market cap has increased by 167.88% in one year.
Market Cap
139.08M
Enterprise Value
132.21M
Revenue
62.85K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.47
ChartMarket Cap Chart
Since April 13, 2021, Island Pharmaceuticals's market cap has increased from 42.51M to 139.08M, an increase of 227.18%. That is a compound annual growth rate of 24.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 139.08M | 20.22% |
| Dec 31, 2025 | 115.69M | 274.76% |
| Dec 31, 2024 | 30.87M | 299.86% |
| Dec 29, 2023 | 7.72M | -48.65% |
| Dec 28, 2022 | 15.03M | -27.45% |
| Dec 31, 2021 | 20.72M | -51.25% |
| Apr 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BLS Pharmaceuticals | 209.28M |
| Orthocell | 198.75M |
| Nyrada | 182.70M |
| Dimerix | 165.11M |
| Actinogen Medical | 153.63M |
| Recce Pharmaceuticals | 112.30M |
| Alterity Therapeutics | 112.02M |
| Paradigm Biopharmaceuticals | 103.95M |